Glenmark Pharmaceuticals Inc., US (Glenmark) has been granted final approval by the US Food and Drug Administration for the extended-cycle oral contraceptive, levonorgestrel/ethinyl estradiol tablets USP, 0.15 mg/0.03 mg, the AB-rated generic version of Seasonaleby Teva Women’s Health.